Eli Lilly and Company's (LLY) CEO Dave Ricks on Q1 2022 Resu

Eli Lilly and Company (NYSE:NYSE:LLY) Q1 2022 Earnings Conference Call April 28, 2022, 9:00 AM ET Company Participants Kevin Hern - Vice President, Investor Relations Dave Ricks - Chair and...

Related Keywords

Taiwan , Japan , United States , China , Boston , Massachusetts , Saudi Arabia , Russia , Canada , Ukraine , Russian , Americans , America , American , Robyn Karnauskas , Mike Mason , Dave Ricks , Andrew Baum , Tim Anderson , Ilya Yuffa , Eli Lilly , Evan Seigerman , Chris Shibutani , Lauren Zierke , Carter Gould , Kevin Hern , Terence Flynn , Alice Nettleton , Kerry Holford , Geoff Meacham , Steve Scala , Anne White , Kento Ueha , Seamus Fernandez , Dan Skovronsky , Louise Chen , Chris Schott , Sara Smith , Patrik Jonsson , Jake Van Naarden , Morgan Stanley , Company Participants , American Academy Of Dermatology Annual Meeting , National Coverage Determination , Goldman Sachs , Boehringer Ingelheim , Wolfe Research , Barclays , Data Monitoring Committee , Lilly Institute For Genetic Medicines , Exchange Commission , Colitis Virtual Congress , Elilly International , Oncology Oncologic Drugs Advisory Committee , Conference Call April , Van Naarden , Executive Officer , Loxo Oncology , Lilly Immunology , Lilly United , Vice President , Anat Ashkenazi , Chief Financial Officer , Chief Scientific , Medical Officer , Lilly Neuroscience , Lilly Oncology , Lilly Diabetes , Investor Relations , Independent Data Monitoring Committee , Use Authorization , Lilly Institute , Genetic Medicines , Priority Review , Europeans Crohn , American Academy , Dermatology Annual Meeting , Drugs Advisory Committee , Federal Health , Umer Raffat , Vamil Divan ,